SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 61.70 |
Enterprise Value ($M) | 34.57 |
Book Value ($M) | 25.37 |
Book Value / Share | 0.40 |
Price / Book | 2.43 |
NCAV ($M) | 17.81 |
NCAV / Share | 0.28 |
Price / NCAV | 3.46 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.28 |
Return on Assets (ROA) | -0.73 |
Return on Equity (ROE) | -1.20 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.22 |
Current Ratio | 2.22 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 37.26 |
Assets | 44.81 |
Liabilities | 19.44 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Slate Path Capital LP | 1.40 | -61.75 | |
13G/A | Bleichroeder LP | 9.99 | 122.42 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
67,124 | 193,008 | 34.78 | |
32,793 | 91,059 | 36.01 | |
54,942 | 168,758 | 32.56 | |
28,059 | 107,237 | 26.17 | |
58,742 | 182,985 | 32.10 | |
(click for more detail) |
Similar Companies | |
---|---|
CSBR – Champions Oncology, Inc. | CSCI – COSCIENS Biopharma Inc. |
CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io